School of Medicine


Showing 1-10 of 49 Results

  • Bernardo Bonilauri

    Bernardo Bonilauri

    Postdoctoral Scholar, Cardiovascular Institute

    BioI am a highly motivated and devoted scientist, deeply committed to advancing our understanding of the molecular foundations of cardiovascular disease while spearheading innovative therapeutic approaches and drug discovery. As a Postdoctoral Research Fellow at the Stanford Cardiovascular Institute, under the guidance of Dr. Joseph C. Wu, I am privileged to contribute to cutting-edge research. My work spans various disciplines, including multi-omics, molecular and cellular biology, tissue engineering, biochemistry, structural biology, and state-of-the-art imaging technologies. This holistic approach and sharp critical thinking equips me to untangle the complexities of cardiac diseases and innovate novel therapeutic strategies, particularly for rare cardiac conditions such as Transthyretin Cardiac Amyloidosis.

  • Arianne Caudal

    Arianne Caudal

    Postdoctoral Scholar, Cardiovascular Institute

    BioDr. Arianne Caudal is a postdoctoral fellow at the Stanford Cardiovascular Institute with research interests in cardiac metabolism, disease modeling, and drug discovery. Dr. Caudal received her PhD in Biochemistry from the University of Washington, after conducting thesis work on mitochondrial metabolism and protein-protein interactions in the heart.

  • Ramzi Emanuel Dudum

    Ramzi Emanuel Dudum

    Clinical Scholar, Medicine - Cardiovascular Medicine
    Masters Student in Health Policy, admitted Autumn 2022

    BioDr. Dudum is a cardiologist and population health expert working to develop novel risk prediction methods and implementation strategies to create practices and systems that allow for reductions in cardiovascular disease. He completed a Masters in Public Health at Johns Hopkins concentrating in epidemiology and biostatistics and a Doctorate of Medicine at George Washington University.

    He completed internal medicine residency training as part of the Osler Medical Service, where he worked under the mentorship of Drs. Roger Blumenthal and Michael Blaha to study improving cardiovascular risk prediction and coronary artery calcium. Given his focus on population health and implementation science, he also helped launch and refine risk adjustment tools and implemented guideline-directed medical care pathways. During his time there, he was recognized for his clinical acumen and dedication to patient care.

    He came to Stanford for his cardiovascular medicine fellowship and continued research in coronary artery calcium under the mentorship of Drs. David Maron and Fatima Rodriguez while also conducting cardiovascular health implementation science work under the mentorship of Dr. Steve Asch. He serves as the co-investigator of a prospective randomized trial testing the effects of notification of incidental coronary artery calcium on statin initiation rates among those with and without cardiovascular disease (NCT 05588895). He has worked with hospital leaders to implement digital health and artificial intelligence tools, creating the infrastructure for the prospective use of AI-algorithms on radiology studies. As a preventive cardiologist and population health expert, he leads efforts in the preventive cardiology section related to improving cardiovascular health.

  • Gracia Fahed, MD

    Gracia Fahed, MD

    Postdoctoral Scholar, Cardiovascular Institute

    BioDr. Fahed earned her medical degree from the American University of Beirut (AUB) in Lebanon. She graduated at the top of her class and was recognized for her outstanding academic achievements and compassionate patient care. Over the course of her medical studies, Dr. Fahed concentrated her research on understanding the pathophysiology behind endothelial dysfunction, hypertension and the metabolic syndrome. As a postdoctoral scholar in the Stanford Cardiovascular Institute, she now focuses on left ventricular diastolic dysfunction and early diagnosis of genetic cardiomyopathy, with a specific focus on transthyretin cardiac amyloidosis, a serious yet often overlooked cause of heart failure. Dr. Fahed aims to improve risk-stratification to enhance diagnostic care and improve cardiovascular outcomes.